ConductScience.org, home

Paper · 6237983

Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration.

Cochran FR and 1 other. Immunology, 1984. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration. Papers, record 6237983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6237983

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration.
PubMed
Journal
Immunology
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cochran FRF R
2Baxter CSC S

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarrageenanMajor topic
Immune ToleranceMajor topic
Lymphocyte ActivationMajor topic
MacrophagesMajor topic
T-LymphocytesMajor topic
Animals
Immunity, Innate
Male
Mitogens
Rats
Rats, Inbred Strains
Spleen
T-Lymphocytes, Regulatory

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ES-07073NIEHS NIH HHSUnited StatesT32ES007073PubMed and NIH

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,288,309An examination of the cytotoxic effects of silica on macrophages.J Exp Med1966https://conductscience.org/library/papers/4288309PubMed
24,108,563The effect of carrageenan on the establishment of delayed hypersensitivity.Int Arch Allergy Appl Immunol1971https://conductscience.org/library/papers/4108563PubMed
35,142,272Spectrum and possible mechanism of carrageenan cytotoxicity.Am J Pathol1971https://conductscience.org/library/papers/5142272PubMed
45,043,336Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the rhesus monkey, Macaca mulatta.Exp Mol Pathol1972https://conductscience.org/library/papers/5043336PubMed
5773,666Evidence for a selective cytotoxic effect of carrageenan on cells of the immune system in vivo and in vitro.Experientia1976https://conductscience.org/library/papers/773666PubMed
6817,996Carrageenan: the effect of molecular weight and polymer type on its uptake, excretion and degradation in animals.Food Cosmet Toxicol1976https://conductscience.org/library/papers/817996PubMed
7958,392Control of lymphokine secretion by prostaglandins.Nature1976https://conductscience.org/library/papers/958392PubMed
8996,859Cecal response to different molecular weights and types of carrageenan in the guinea pig.Toxicol Appl Pharmacol1976https://conductscience.org/library/papers/996859PubMed
966,280Effects of carrageenan on immune responses. Studies on the macrophage dependency of various antigens after treatment with carrageenan.J Immunol1977https://conductscience.org/library/papers/66280PubMed
10205,609The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages.J Immunol1978https://conductscience.org/library/papers/205609PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn Papers
32,938,835Oral λ-carrageenan intake alleviates skin symptoms in a hapten induced atopic dermatitis-like model.J Vet Med Sci2020https://conductscience.org/library/papers/32938835

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6237983

GET https://conductscience.org/api/papers/v1/6237983/authors